EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 262 filers reported holding EDITAS MEDICINE INC in Q3 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,061 | +13.6% | 23,213 | +19.8% | 0.00% | +100.0% |
| Q2 2023 | $159,432 | +10.4% | 19,372 | -2.8% | 0.00% | 0.0% |
| Q1 2023 | $144,449 | -16.0% | 19,924 | +2.7% | 0.00% | -50.0% |
| Q4 2022 | $172,043 | -24.5% | 19,396 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $228,000 | +4.1% | 18,653 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $219,000 | -37.8% | 18,536 | +0.3% | 0.00% | -33.3% |
| Q1 2022 | $352,000 | -27.9% | 18,489 | +0.6% | 0.00% | -25.0% |
| Q4 2021 | $488,000 | -35.7% | 18,372 | -0.6% | 0.00% | -33.3% |
| Q3 2021 | $759,000 | -26.8% | 18,475 | +0.9% | 0.01% | -25.0% |
| Q2 2021 | $1,037,000 | +36.1% | 18,311 | +0.9% | 0.01% | +14.3% |
| Q1 2021 | $762,000 | -39.8% | 18,146 | +0.5% | 0.01% | -36.4% |
| Q4 2020 | $1,266,000 | +145.3% | 18,058 | -1.9% | 0.01% | +120.0% |
| Q3 2020 | $516,000 | +41.0% | 18,405 | +48.6% | 0.01% | 0.0% |
| Q2 2020 | $366,000 | +70.2% | 12,386 | +14.3% | 0.01% | +25.0% |
| Q1 2020 | $215,000 | – | 10,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |